158001-21-9 Usage
General Description
1-CYCLOBUTYLHYDRAZINE HYDROCHLORIDE is a chemical compound with the formula C4H10N2?HCl. It is a hydrazine derivative, and its molecular structure contains a cyclobutyl group. 1-CYCLOBUTYLHYDRAZINE HYDROCHLORIDE is commonly used in organic synthesis as a reagent for the preparation of various pharmaceuticals and agrochemicals. It is also used as a precursor in the manufacturing of rubber chemicals and as a corrosion inhibitor. 1-CYCLOBUTYLHYDRAZINE HYDROCHLORIDE is a colorless to light yellow crystalline solid that is soluble in water and other polar solvents. It should be handled and stored with proper safety precautions due to its toxic and potentially hazardous properties.
Check Digit Verification of cas no
The CAS Registry Mumber 158001-21-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,0,0 and 1 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 158001-21:
(8*1)+(7*5)+(6*8)+(5*0)+(4*0)+(3*1)+(2*2)+(1*1)=99
99 % 10 = 9
So 158001-21-9 is a valid CAS Registry Number.
InChI:InChI=1/C4H10N2.ClH/c5-6-4-2-1-3-4;/h4,6H,1-3,5H2;1H
158001-21-9Relevant articles and documents
COMPOUNDS USEFUL AS KINASE INHIBITORS
-
Paragraph 00295, (2017/07/14)
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK).The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
-
, (2008/06/13)
Novel 6-heterocyclyl-pyrazolo[3,4-d]pyrimidin-4-ones, useful in treating cardiovascular disease, are prepared by reacting a 5-amino-1H-pyrazole-4-carboxamide with heterocyclylcarboxaldehyde or by reacting a 5-amino-1H-pyrazole-4-carbonitrile with a heterocyclylcarboxamidine, followed by diazotization and hydrolysis of the resulting 4-amino-6-heterocyclyl-pyrazolo[3,4-d]pyrimidine.
